Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Requip (ropinirole hydrochloride) Tablets, GlaxoSmithKline NDA 20-658 / S012 | REQUIP (ropinirole hydrochloride) Tablets, SmithKline Beecham, New or Modified Indication | Ropinirole Hydrochloride Tablets, Roxane Labs, Tentative Approval | Ropinirole Hydrochloride Tablets, Par Pharma, Tentative Approval | Ropinirole Hydrochloride Tablets, Par Pharma, Tentative Approval | Ropinirole Hydrochloride Tablets, Teva Pharma, Tentative Approval | Ropinirole Hydrochloride Tablets, Mylan Pharmaceuticals Inc., Approval | Ropinirole Hydrochloride Tablets, Teva Pharmaceuticals, Approval | Ropinirole Hydrochloride Tablets, Roxane Laboratories, Inc., Approval | Ropinirole Hydrochloride Tablets, Par Pharmaceutical, Inc., Approval | Ropinirole Hydrochloride Tablets, Corepharma, LLC, Approval | Ropinirole Hydrochloride Tablets, Wockhardt USA, Inc., Approval | Requip XL (ropinirole) Extended-Release Tablets, GlaxoSmithKline, Approval | Requip XL (ropinirole) Extended-Release Tablets, GlaxoSmithKline, Approval | Requip XL (ropinirole hydrochloride) Extended-Release Tablets, GlaxoSmithKline, Formulation Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com